CO4940486A1 - Composiciones anti-fungosas - Google Patents
Composiciones anti-fungosasInfo
- Publication number
- CO4940486A1 CO4940486A1 CO97020212A CO97020212A CO4940486A1 CO 4940486 A1 CO4940486 A1 CO 4940486A1 CO 97020212 A CO97020212 A CO 97020212A CO 97020212 A CO97020212 A CO 97020212A CO 4940486 A1 CO4940486 A1 CO 4940486A1
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutically acceptable
- fungous
- compositions
- effective
- amount
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición farmacéutica para administración intravenosa aun paciente, que comprende a) una cantidad farmacéuticamente efectiva de un compuesto que tiene la Fórmula y sus sales farmacéuticamente aceptables,b) una cantidad farmacéuticamente aceptable de un excipiente tal como un agente de volumen efectivo para formar una torta liofilizada; y c) una cantidad farmacéuticamente aceptable de un tampón acetato efectivo para proveer un pH farmacéuticamente aceptable.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1563896P | 1996-04-19 | 1996-04-19 | |
| GBGB9611006.9A GB9611006D0 (en) | 1996-05-24 | 1996-05-24 | Antifungal compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4940486A1 true CO4940486A1 (es) | 2000-07-24 |
Family
ID=26309400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97020212A CO4940486A1 (es) | 1996-04-19 | 1997-04-17 | Composiciones anti-fungosas |
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP0904098B1 (es) |
| JP (1) | JP3258672B2 (es) |
| CN (1) | CN1132624C (es) |
| AR (1) | AR006598A1 (es) |
| AT (1) | ATE241999T1 (es) |
| AU (1) | AU706250B2 (es) |
| BG (1) | BG64272B1 (es) |
| BR (2) | BRPI9708706C8 (es) |
| CA (1) | CA2251928C (es) |
| CO (1) | CO4940486A1 (es) |
| CY (1) | CY2374B1 (es) |
| CZ (1) | CZ289361B6 (es) |
| DE (1) | DE69722615T2 (es) |
| DK (1) | DK0904098T3 (es) |
| DZ (1) | DZ2205A1 (es) |
| EA (1) | EA001386B1 (es) |
| EE (1) | EE04265B1 (es) |
| ES (1) | ES2198569T3 (es) |
| HR (1) | HRP970201B1 (es) |
| HU (1) | HU228296B1 (es) |
| ID (1) | ID16643A (es) |
| IL (1) | IL126479A (es) |
| IS (1) | IS2159B (es) |
| MY (1) | MY126305A (es) |
| NO (1) | NO321954B1 (es) |
| NZ (1) | NZ332156A (es) |
| PE (1) | PE63998A1 (es) |
| PL (1) | PL187294B1 (es) |
| PT (1) | PT904098E (es) |
| RS (1) | RS49566B (es) |
| SA (1) | SA97180104B1 (es) |
| SK (1) | SK281969B6 (es) |
| TR (1) | TR199802102T2 (es) |
| UA (1) | UA55409C2 (es) |
| WO (1) | WO1997039763A1 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970318B1 (en) | 1996-06-14 | 2002-06-30 | Merck & Co Inc | A process for preparing certain aza cyclohexapeptides |
| PT1582204E (pt) * | 1999-03-03 | 2013-11-25 | Lilly Co Eli | Formulações farmacêuticas de equinocandina que contêm tensioactivos que formam micelas |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| KR101536781B1 (ko) * | 2006-07-26 | 2015-07-14 | 산도즈 아게 | 카스포펀진 제형 |
| CN101516387B (zh) * | 2006-07-26 | 2014-06-04 | 桑多斯股份公司 | 卡泊芬净制剂 |
| US20100137197A1 (en) * | 2007-06-26 | 2010-06-03 | Sachin Mittal | Lyophilized anti-fungal composition |
| US8048853B2 (en) | 2008-06-13 | 2011-11-01 | Xellia Pharmaceuticals Aps | Process for preparing pharmaceutical compound and intermediates thereof |
| WO2010008493A2 (en) * | 2008-06-25 | 2010-01-21 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Processes for preparing high purity aza cyclohexapeptides |
| WO2010108637A1 (en) * | 2009-03-27 | 2010-09-30 | Axellia Pharmaceuticals Aps | Crystalline compound |
| CN102219832B (zh) * | 2010-04-15 | 2013-08-21 | 上海天伟生物制药有限公司 | 一种氮杂环六肽或其盐的纯化方法 |
| CN102367267B (zh) * | 2010-11-10 | 2013-09-04 | 上海天伟生物制药有限公司 | 一种卡泊芬净的制备方法 |
| CN102367268B (zh) * | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其用途 |
| CN102367269B (zh) * | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其制备方法和用途 |
| CN102488887B (zh) * | 2011-01-31 | 2014-06-18 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途 |
| CN102488888B (zh) * | 2011-01-31 | 2014-07-30 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途 |
| CN102614493B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物 |
| NO2680873T3 (es) | 2011-03-03 | 2018-01-06 | ||
| CN102166186A (zh) * | 2011-04-18 | 2011-08-31 | 深圳市健元医药科技有限公司 | 一种更加稳定的氮杂环己肽类制剂 |
| CN102488886B (zh) * | 2011-09-26 | 2014-03-26 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| CN102488889B (zh) * | 2011-09-26 | 2014-01-22 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| CN103212059A (zh) * | 2012-01-18 | 2013-07-24 | 江苏恒瑞医药股份有限公司 | 含有抗真菌药物和乳酸盐缓冲液的组合物 |
| HRP20231151T1 (hr) | 2012-03-19 | 2024-01-05 | Cidara Therapeutics, Inc. | Režimi za doziranje spojeva iz klase ehinokandina |
| CN105164146B (zh) * | 2013-05-02 | 2019-06-28 | 灿盛制药有限公司荷兰公司 | 分离卡泊芬净的方法 |
| PL3058958T3 (pl) | 2015-02-23 | 2019-02-28 | Selectchemie Ag | Kompozycja anidulafunginy |
| CN109154603A (zh) | 2016-03-16 | 2019-01-04 | 奇达拉治疗公司 | 用于治疗真菌感染的给药方案 |
| CN111050798A (zh) | 2017-07-12 | 2020-04-21 | 奇达拉治疗公司 | 用于治疗真菌感染的组合物和方法 |
| CN109721641B (zh) * | 2017-10-31 | 2021-08-03 | 鲁南制药集团股份有限公司 | 一种卡泊芬净的合成方法 |
| CN113801202B (zh) * | 2020-06-15 | 2024-11-05 | 杭州中美华东制药有限公司 | 一种醋酸卡泊芬净杂质g的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1234383A (en) * | 1982-03-17 | 1983-09-22 | Inter-Yeda Ltd. | Interferon stabilised with polyvinyl-pyrrolidone |
| WO1989011297A1 (en) * | 1988-05-27 | 1989-11-30 | Centocor, Inc. | Freeze-dried formulation for antibody products |
| US5939384A (en) * | 1991-10-01 | 1999-08-17 | Merck & Co., Inc. | Cyclohexapeptidyl propanolamine compounds |
| DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
| US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
| IL109350A (en) * | 1993-05-12 | 2001-01-28 | Genentech Inc | Stable liquid compositions of gamma interferon |
-
1997
- 1997-04-10 AR ARP970101437A patent/AR006598A1/es active IP Right Grant
- 1997-04-10 PE PE1997000281A patent/PE63998A1/es not_active IP Right Cessation
- 1997-04-11 HR HR970201A patent/HRP970201B1/xx not_active IP Right Cessation
- 1997-04-15 DZ DZ970052A patent/DZ2205A1/fr active
- 1997-04-15 UA UA98116109A patent/UA55409C2/uk unknown
- 1997-04-15 JP JP53815697A patent/JP3258672B2/ja not_active Expired - Lifetime
- 1997-04-15 AT AT97921205T patent/ATE241999T1/de active
- 1997-04-15 CZ CZ19983347A patent/CZ289361B6/cs not_active IP Right Cessation
- 1997-04-15 IL IL126479A patent/IL126479A/en not_active IP Right Cessation
- 1997-04-15 HU HU9901586A patent/HU228296B1/hu unknown
- 1997-04-15 DE DE69722615T patent/DE69722615T2/de not_active Expired - Lifetime
- 1997-04-15 BR BRPI9708706A patent/BRPI9708706C8/pt not_active IP Right Cessation
- 1997-04-15 NZ NZ332156A patent/NZ332156A/xx not_active IP Right Cessation
- 1997-04-15 SK SK1448-98A patent/SK281969B6/sk not_active IP Right Cessation
- 1997-04-15 EE EE9800345A patent/EE04265B1/xx unknown
- 1997-04-15 ES ES97921205T patent/ES2198569T3/es not_active Expired - Lifetime
- 1997-04-15 CA CA002251928A patent/CA2251928C/en not_active Expired - Lifetime
- 1997-04-15 TR TR1998/02102T patent/TR199802102T2/xx unknown
- 1997-04-15 BR BRPI9708706A patent/BR9708706B8/pt active IP Right Grant
- 1997-04-15 WO PCT/US1997/006284 patent/WO1997039763A1/en not_active Ceased
- 1997-04-15 CN CN97195514A patent/CN1132624C/zh not_active Expired - Lifetime
- 1997-04-15 PL PL97329442A patent/PL187294B1/pl unknown
- 1997-04-15 EP EP97921205A patent/EP0904098B1/en not_active Expired - Lifetime
- 1997-04-15 PT PT97921205T patent/PT904098E/pt unknown
- 1997-04-15 EA EA199800938A patent/EA001386B1/ru not_active IP Right Cessation
- 1997-04-15 DK DK97921205T patent/DK0904098T3/da active
- 1997-04-15 AU AU27311/97A patent/AU706250B2/en not_active Expired
- 1997-04-17 ID IDP971282A patent/ID16643A/id unknown
- 1997-04-17 CO CO97020212A patent/CO4940486A1/es unknown
- 1997-04-17 MY MYPI97001663A patent/MY126305A/en unknown
- 1997-05-31 SA SA97180104A patent/SA97180104B1/ar unknown
-
1998
- 1998-10-02 IS IS4858A patent/IS2159B/is unknown
- 1998-10-15 RS YUP-450/98A patent/RS49566B/sr unknown
- 1998-10-16 NO NO19984860A patent/NO321954B1/no not_active IP Right Cessation
- 1998-10-19 BG BG102857A patent/BG64272B1/bg unknown
-
2003
- 2003-08-25 CY CY0300058A patent/CY2374B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940486A1 (es) | Composiciones anti-fungosas | |
| DE69328192D1 (de) | Injizierbare Arzneizubereitungen enthaltend Taxanderivate | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| YU13695A (sh) | Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije | |
| NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
| ES2195344T3 (es) | Composicion farmaceutica que presenta una actividad antitumoral mejorada y/o efectos secundarios reducidos, que contiene un agente antitumoral y un derivado de acido hidroximico. | |
| CO4940450A1 (es) | Formulaciones farmaceuticas que contienen voriconazol | |
| ES2190075T3 (es) | Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico. | |
| CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
| TW427906B (en) | Antifungal compositions | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| SE8402560D0 (sv) | Farmaceutisk komposition | |
| ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| ATE268174T1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
| SE9403137D0 (sv) | Derivatives of carbohydrates and compositions containing them | |
| CO4770960A1 (es) | Composiciones antagonistas receptoras de butilsulfonilamino fibrinogeno para inhibir la agregacion de plaquetas | |
| ECSP972084A (es) | Composiciones que comprenden un agente antifungoso y un tampon de acetato | |
| UY23397A1 (es) | Composicion y metodo de pro-droga de 5-fluorouracilo topica | |
| ATE301469T1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
| EE200100196A (et) | a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks | |
| IL147901A0 (en) | Phenanthroline-7-one derivatives and their therapeutic uses | |
| ATE109981T1 (de) | Therapeutische mittel. | |
| GB1397893A (en) | Pharmaceutical compositions | |
| AR057123A1 (es) | Composicion farmaceutica estable que contiene una pirimidina-sulfamida |